Woodline Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12M | Sell |
95,560
-29,602
| -24% | -$3.72M | 0.06% | 385 |
|
|
2025
Q1 | $17.1M | Buy |
125,162
+37,005
| +42% | +$5.06M | 0.11% | 256 |
|
|
2024
Q4 | $13.5M | Buy |
88,157
+5,874
| +7% | +$898K | 0.09% | 287 |
|
|
2024
Q3 | $15.9M | Buy |
82,283
+1,683
| +2% | +$326K | 0.13% | 218 |
|
|
2024
Q2 | $18.7M | Hold |
80,600
| – | – | 0.18% | 174 |
|
|
2024
Q1 | $17.4M | Hold |
80,600
| – | – | 0.16% | 191 |
|
|
2023
Q4 | $20.9M | Buy |
+80,600
| New | +$20.9M | 0.23% | 134 |
|
|
2023
Q3 | – | Sell |
-2,213
| Closed | -$630K | – | 599 |
|
|
2023
Q2 | $630K | Sell |
2,213
-140,865
| -98% | -$40.1M | 0.01% | 518 |
|
|
2023
Q1 | $39.8M | Buy |
143,078
+107,569
| +303% | +$29.9M | 0.54% | 38 |
|
|
2022
Q4 | $9.83M | Sell |
35,509
-38,445
| -52% | -$10.6M | 0.13% | 211 |
|
|
2022
Q3 | $19.7M | Buy |
73,954
+36,542
| +98% | +$9.76M | 0.28% | 102 |
|
|
2022
Q2 | $7.63M | Sell |
37,412
-16,655
| -31% | -$3.4M | 0.12% | 204 |
|
|
2022
Q1 | $11.4M | Buy |
54,067
+16,286
| +43% | +$3.43M | 0.18% | 159 |
|
|
2021
Q4 | $9.06M | Sell |
37,781
-14,637
| -28% | -$3.51M | 0.13% | 208 |
|
|
2021
Q3 | $14.8M | Sell |
52,418
-21,039
| -29% | -$5.95M | 0.24% | 111 |
|
|
2021
Q2 | $25.4M | Buy |
73,457
+55,981
| +320% | +$19.4M | 0.47% | 53 |
|
|
2021
Q1 | $4.89M | Buy |
+17,476
| New | +$4.89M | 0.11% | 198 |
|